EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

​Consideration of sex/gender aspects in cardiovascular clinical trials

Maximilian Bley, Linda Mathez, Susanne Menz, Isabella Stephan, Vera Regitz-Zagrosek, Marc J Lerchenmueller, Carolin Lerchenmüller

Clinical Research in Cardiology · 2025-12 · 114 (12) · 1752-1764

DOI: 10.1007/s00392-025-02793-3 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical Research in Cardiology, online erschienen am 26.11.2025. Verfasst von Maximilian Bley und 6 weiteren Autor:innen. Beteiligte Einrichtung: Chair for Gender Medicine, University of Zurich, Zurich, 8006, Switzerland. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Clinical Trials as Topic, Gender Equity. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Zurich.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Understanding sex/gender in the context of health and disease is critical to deliver the best care. However, sex/gender have not been consistently considered in cardiovascular clinical trials. Global initiatives, including the Sex and Gender Equity in Research (SAGER)-guidelines, aim to improve the quality of the reporting, but it remains unclear if they are used consistently.

Methods

We conducted a systematic analysis of cardiovascular clinical trials published in PubMed between 2018 and 2024. To investigate the representation of women/females, we first analyzed the participation-prevalence-ratio (PPR). Second, we measured sex/gender-sensitive reporting (SGR) applying modified SAGER-guidelines. In addition, we determined whether study author sex/gender impacts the other variables.

Findings

We identified 1593 clinical trials with a total of 716,569 woman/female participants (38.5%). The median PPR of all trials remained suboptimal at 0.77 (95%-CI: 0.74–0.79) throughout the years with a modest positive trend towards 2024 and significant underrepresentation in some disease entities (e.g., ischemic heart disease, heart failure). Analyzing an evenly distributed sample of 632 trials, we found suboptimal SGR, especially for endpoints and discussions. We found a positive correlation of increased participation of women/females and SGR with women/females as authors.

Interpretation

Our results suggest an ongoing imbalance for the participation of women/females and suboptimal SGR in cardiovascular clinical trials, especially for certain diseases, with a modest positive trend. More women/females in the authorship team correlate with an increased PPR and are associated with an increase in SGR. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesClinical Trials as TopicGender EquityHumansFemaleSex FactorsMale

Stichwörter der Autor:innen

Cardiovascular medicineClinical trialsGender equityParticipationReporting

Autor:innen und Institutionen

  • Chair for Gender Medicine, University of Zurich, Zurich, 8006, Switzerland.
  • Department of Cardiology, University Hospital Zurich, Zurich, 8091, Switzerland.
  • Institute of Gender in Medicine, Charité Universitaetsmedizin Berlin, Berlin, 10115, Germany.
  • University of Mannheim, Mannheim, 68161, Germany.
  • Leibniz Centre for European Economic Research, Mannheim, 68161, Germany.
  • Chair for Gender Medicine, University of Zurich, Zurich, 8006, Switzerland. carolin.lerchenmueller@uzh.ch.

Förderung

  • University of Zurich

Zitieren

APA

Bley, M., Mathez, L., Menz, S., Stephan, I., Regitz-Zagrosek, V., Lerchenmueller, M. J., & Lerchenmüller, C. (2025). ​Consideration of sex/gender aspects in cardiovascular clinical trials. Clinical Research in Cardiology, 114(12), 1752-1764. https://doi.org/10.1007/s00392-025-02793-3

Vancouver

Bley M, Mathez L, Menz S, Stephan I, Regitz-Zagrosek V, Lerchenmueller MJ, et al. ​Consideration of sex/gender aspects in cardiovascular clinical trials. Clinical Research in Cardiology. 2025;114(12):1752-1764. doi:10.1007/s00392-025-02793-3

BibTeX
@article{Bley2025,
  author = {Bley, Maximilian and Mathez, Linda and Menz, Susanne and Stephan, Isabella and Regitz-Zagrosek, Vera and Lerchenmueller, Marc J and Lerchenmüller, Carolin},
  title = {​Consideration of sex/gender aspects in cardiovascular clinical trials},
  journal = {Clinical Research in Cardiology},
  year = {2025},
  volume = {114},
  number = {12},
  pages = {1752--1764},
  doi = {10.1007/s00392-025-02793-3}
}
Kostenlos starten →